Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
3.03
-0.16 (-5.02%)
At close: Aug 15, 2025, 3:59 PM
3.09
1.98%
After-hours: Aug 15, 2025, 07:48 PM EDT
Protara Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 332K | 332K | 332K | 1.21M | 1.21M | 1.21M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 265K | 250K | 250K | 357K | 380K | 717K | 711K | 678K | 635K | 610K | 930K | 856K | 792K | 452K | 87K | 87K | 87K | 32K |
Gross Profit | -99K | -84K | -84K | 851K | 828K | 491K | 497K | -678K | -635K | -610K | -930K | -856K | -792K | -452K | -87K | -87K | -87K | -32K |
Operating Income | -57.35M | -51.43M | -49.15M | -45.88M | -44.25M | -45.73M | -43.61M | -12.1M | -9.37M | -5.94M | -7.08M | -37.84M | -40.7M | -44.78M | -47.49M | -46.16M | -43.39M | -37.86M |
Interest Income | 5.58M | 5.11M | 4.13M | 3.8M | 3.54M | 3.24M | 3.18M | 3M | 2.72M | 2.39M | 2.23M | 3.39M | 3.38M | 3.38M | 3.25M | 1.46M | 1M | 615K |
Pretax Income | -50.86M | -45.41M | -44.6M | -42.05M | -40.69M | -42.47M | -40.42M | -69.17M | -67M | -64.24M | -65.95M | -37.21M | -40.3M | -44.54M | -47.25M | -45.83M | -43.02M | -37.38M |
Net Income | -50.86M | -45.41M | -44.6M | -42.05M | -40.69M | -42.47M | -39.73M | -68.37M | -65.92M | -62.82M | -65.1M | -36.47M | -39.83M | -44.42M | -47.25M | -45.83M | -43.02M | -37.38M |
Selling & General & Admin | 19.86M | 18.32M | 17.45M | 17.19M | 17.41M | 18.03M | 18.52M | 18.97M | 18.99M | 19.72M | 20.74M | 21.95M | 24.18M | 25.47M | 26.4M | 25.49M | 24.02M | 21.91M |
Research & Development | 37.49M | 33.1M | 31.62M | 28.5M | 26.65M | 27.51M | 24.99M | 23.6M | 20.84M | 16.68M | 16.81M | 15.89M | 16.51M | 19.32M | 21.09M | 20.67M | 19.37M | 15.96M |
Other Expenses | n/a | n/a | n/a | 107K | 107K | 107K | 107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 57.35M | 51.43M | 49.07M | 45.8M | 44.17M | 45.65M | 43.61M | 42.56M | 39.84M | 36.4M | 37.55M | 37.84M | 40.7M | 44.78M | 47.49M | 46.16M | 43.39M | 37.86M |
Interest Expense | 1.63M | n/a | n/a | n/a | n/a | n/a | n/a | 107K | 381K | 727K | 1.14M | 1.03M | 1.25M | 1.41M | 1.28M | 1.28M | 785K | 282K |
Selling & Marketing Expenses | n/a | n/a | n/a | -107K | -107K | -107K | -107K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 57.35M | 51.43M | 49.15M | 45.88M | 44.25M | 45.73M | 43.61M | 42.56M | 39.84M | 36.4M | 37.55M | 37.84M | 40.7M | 44.78M | 47.49M | 46.16M | 43.39M | 37.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -687K | -794K | -1.08M | -1.42M | -855K | -748K | -441K | -95K | 24K | 24K | 21.24K | 41.47K |
Shares Outstanding (Basic) | 42.27M | 40.71M | 26.43M | 22.33M | 21.23M | 11.42M | 11.36M | 11.35M | 11.31M | 11.3M | 11.27M | 11.27M | 11.26M | 11.25M | 11.24M | 11.24M | 11.23M | 11.23M |
Shares Outstanding (Diluted) | 42.27M | 40.71M | 26.43M | 22.33M | 21.23M | 11.42M | 11.36M | 11.35M | 11.31M | 11.3M | 11.27M | 11.27M | 11.26M | 11.25M | 11.24M | 11.24M | 11.23M | 11.23M |
EPS (Basic) | -1.62 | -1.72 | -2.4 | -2.82 | -3.19 | -3.74 | -3.51 | -6.06 | -5.85 | -5.58 | -5.79 | -3.25 | -3.55 | -3.96 | -4.21 | -4.09 | -4.39 | -4.47 |
EPS (Diluted) | -1.62 | -1.72 | -2.4 | -2.82 | -3.19 | -3.74 | -3.51 | -6.06 | -5.85 | -5.58 | -5.79 | -3.25 | -3.55 | -3.96 | -4.21 | -4.08 | -4.38 | -4.46 |
EBITDA | -57.19M | -51.18M | -48.82M | -45.53M | -43.9M | -45.38M | -43.27M | -71.12M | -67.86M | -63.59M | -64.3M | -35.74M | -39.17M | -44.09M | -47.17M | -45.83M | -43.09M | -37.49M |
EBIT | -53.52M | -49.22M | -49.15M | -45.88M | -44.25M | -45.73M | -43.61M | -71.43M | -68.15M | -64.2M | -64.81M | -36.18M | -39.05M | -43.13M | -46.26M | -44.98M | -42.76M | -37.75M |
Depreciation & Amortization | 249K | 332K | 332K | 357K | 380K | 717K | 711K | 678K | 635K | 610K | 930K | 910K | 1.53M | 1.19M | 829K | 838.98K | 177.98K | 116.98K |